It is a pharma private limited company based in Mumbai, Maharashtra, India, established in 2022.
2022 | Mumbai, Maharashtra, India | ActiveCatlin Pharmaceuticals Private Limited, a active private limited company, was established on 31 August 2022 in Mumbai, Maharashtra, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24290MH2022PTC389693. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹1.00 M.
Employing 16 professional, Its leadership includes Kunal Khanna (Director), Kul Bhushan Wanchoo (Director), Manik Kak (Director). Past directors included Manik Kak. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 1004,Oberoi Prisma,Cts No 1 B Of Majas Jvlr Road,Opp Majas Depot,Jogeswari (E), Mumbai, Maharashtra, 400060.
U24290MH2022PTC389693
389693
31 August 2022
₹1.00 M
₹1.00 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Catlin Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Kunal Khanna | Director | 31 Aug 2022 | Current |
| Kul Bhushan Wanchoo | Director | 31 Aug 2022 | Current |
| Manik Kak | Director | 08 Oct 2022 | Current |
| Shuja Mubarak Noorani | Director | 21 Aug 2025 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 29 Sep 2023 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Enhance accessibility to Catlin Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
In 2023, Catlin Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Catlin Pharmaceuticals has a workforce of 16 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Catlin Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Catlin Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Shuja Mubarak Noorani was appointed as a Director was appointed as a Director on 21 Aug 2025 & has been associated with this company since 3 months 16 days . was recorded as a recent event.
The activity Catlin Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Progress on Catlin Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was documented.
Manik Kak was appointed as a Director was appointed as a Director on 08 Oct 2022 & has been associated with this company since 3 years 1 month . was recorded as a recent event.
Progress on Kunal Khanna was appointed as a Director was appointed as a Director on 31 Aug 2022 & has been associated with this company since 3 years 3 months . was documented.
Progress on Kul Bhushan Wanchoo was appointed as a Director was appointed as a Director on 31 Aug 2022 & has been associated with this company since 3 years 3 months . was documented.
The CIN of Catlin Pharmaceuticals Private Limited is U24290MH2022PTC389693.
Catlin Pharmaceuticals Private Limited is headquartered at 1004,Oberoi Prisma,Cts No 1 B Of Majas Jvlr Road,Opp Majas Depot,Jogeswari (E), Mumbai, Maharashtra, 400060.
Catlin Pharmaceuticals Private Limited was incorporated on 31 August 2022.
The current directors of Catlin Pharmaceuticals Private Limited are
The primary industry of Catlin Pharmaceuticals Private Limited is Manufacturing.
Catlin Pharmaceuticals Private Limited is unlisted.
The authorized capital of Catlin Pharmaceuticals Private Limited is ₹1.00 M, and the paid-up capital is ₹1.00 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX